Compass Pathways Plc buy BiotechBee
Start price
08.06.25
/
60%
€4.26
Target price
31.08.27
€8.00
Performance (%)
-43.66%
End price
29.06.25
€2.40
Summary
This prediction ended on 29.06.25 with a price of €2.40. The BUY prediction by BiotechBee for Compass Pathways Plc performed very badly with a performance of -43.66%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Compass Pathways Plc | - | - |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
According to BiotechBee what are the pros and cons of Compass Pathways Plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year